Moss, 28 February 2019
Gentian Diagnostics AS announces its results for the 4th quarter and 2018 preliminary annual results. The highlights include:
• Record sales revenues of MNOK 11.1 for the quarter
• 42 % growth in underlying sales revenue compared to 4Q17, 43 % year to date
• All time high sales results achieved with fCAL® turbo
Please find the report enclosed. The report will also be made available on www.gentian.no.
For further information, please contact:
Hilja Ibert
CEO, Gentian Diagnostics
E-mail: hilja.ibert@gentian.no
Cell Phone: +47 919 05 242
Njaal Kind
CFO, Gentian Diagnostics
E-mail: njaal.kind@gentian.no
Cell Phone. +47 919 06 525